SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Grandy who wrote (516)3/20/1997 8:15:00 PM
From: Pete Holm   of 6136
 
I'm not sure if AGPH is actively seeking a synergy claim with other protease inhibitors. I definately do not know if they are doing any multidrug trials with other agents. The feedback I get is from my doctor friends. What I referred to when I said the "AGPH/ROHHY combination" is Agouron's Viracept with Roche's Inverase appears to show the best results in preliminary observations of combination protease inhibitor therapy..
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext